GenVec Inc. Names Mark O. Thornton, MD, MPH, PhD As Senior Vice President, Clinical Development

GAITHERSBURG, Md.--(BUSINESS WIRE)--GenVec, Inc. (Nasdaq:GNVC) announced today the appointment of Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development. Dr. Thornton was formerly Chief Medical Officer at ZIOPHARM, Inc., and most recently Managing Director, Clinical and Regulatory Affairs at Angiotech Pharmaceuticals. He also has over 6 years experience as a Medical Officer at the Food and Drug Administration (FDA) Center for Biologics (CBER).
MORE ON THIS TOPIC